We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+4.44%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.49B
AUM Growth
+$60.2M
Cap. Flow
+$11.8M
Cap. Flow %
0.79%
Top 10 Hldgs %
38.05%
Holding
161
New
4
Increased
69
Reduced
20
Closed
5

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$10.9M
2
KLAC icon
KLA
KLAC
+$3.03M
3
WDC icon
Western Digital
WDC
+$2.92M
4
CHKP icon
Check Point Software Technologies
CHKP
+$2.49M
5
AAPL icon
Apple
AAPL
+$1.63M

Top Sells

Rank Stock Value
1
CSRA
CSRA Inc.
CSRA
+$13.6M
2
JPM icon
JPMorgan Chase
JPM
+$9.98M
3
AZN icon
AstraZeneca
AZN
+$1.22M
4
BDX icon
Becton Dickinson
BDX
+$1.19M
5
GLW icon
Corning
GLW
+$1.13M

Sector Composition

Rank Sector Weight
1 Technology 36.4%
2 Financials 16.86%
3 Communication Services 15.69%
4 Healthcare 12.35%
5 Consumer Discretionary 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HPQ icon
51
HP
HPQ
$23.5B
$10M 0.67%
441,831
+11,000
+3% +$245K
COF icon
52
Capital One
COF
$124B
$9.38M 0.63%
102,091
+2,839
+3% +$269K
JPM icon
53
JPMorgan Chase
JPM
$939B
$8.55M 0.57%
82,050
-90,975
-53% -$9.98M
STI
54
DELISTED
SunTrust Banks, Inc.
STI
$8.46M 0.57%
128,180
+505
+0.4% +$34.3K
TRV icon
55
Travelers Companies
TRV
$80.8B
$7.95M 0.53%
64,958
+205
+0.3% +$26.9K
PFE icon
56
Pfizer
PFE
$140B
$7.45M 0.5%
216,544
+121
+0.1% +$4.13K
CRM icon
57
Salesforce
CRM
$134B
$7.25M 0.49%
53,150
MCK icon
58
McKesson
MCK
$98.5B
$7.03M 0.47%
52,675
+8,190
+18% +$1.2M
WFC icon
59
Wells Fargo
WFC
$261B
$6.89M 0.46%
124,255
+1,565
+1% +$83.8K
HBI
60
DELISTED
Hanesbrands
HBI
$6.56M 0.44%
297,820
+31,350
+12% +$591K
GLW icon
61
Corning
GLW
$126B
$6.5M 0.44%
236,306
-40,998
-15% -$1.13M
GNTX icon
62
Gentex
GNTX
$4.88B
$5.93M 0.4%
257,600
+2,960
+1% +$70.2K
MRVL icon
63
Marvell Technology
MRVL
$174B
$5.67M 0.38%
264,630
+40,000
+18% +$854K
ELV icon
64
Elevance Health
ELV
$81.9B
$5.24M 0.35%
22,000
-590
-3% -$137K
AIZ icon
65
Assurant
AIZ
$13.7B
$5.1M 0.34%
49,320
+2,345
+5% +$221K
HRB icon
66
H&R Block
HRB
$5.18B
$4.88M 0.33%
214,205
+14,860
+7% +$394K
HPE icon
67
Hewlett Packard
HPE
$63.2B
$4.77M 0.32%
326,726
+17,000
+5% +$282K
SNY icon
68
Sanofi
SNY
$104B
$4.59M 0.31%
114,840
+250
+0.2% +$9.84K
BIIB icon
69
Biogen
BIIB
$29.9B
$4.39M 0.29%
15,135
+365
+2% +$103K
EG icon
70
Everest Group
EG
$15.2B
$4.36M 0.29%
18,899
+100
+0.5% +$23.5K
SYF icon
71
Synchrony
SYF
$23.7B
$4.32M 0.29%
129,390
+39,660
+44% +$1.36M
WU icon
72
Western Union
WU
$2.57B
$4.28M 0.29%
210,450
+6,150
+3% +$122K
WAT icon
73
Waters Corp
WAT
$36.8B
$4.18M 0.28%
21,620
VVX icon
74
V2X
VVX
$2.62B
$3.2M 0.21%
103,910
-2,382
-2% -$80.6K
AET
75
DELISTED
Aetna Inc
AET
$3.18M 0.21%
17,340

Similar funds

Oak Associates's Q2 2018 Portfolio in Review

As of Q2 2018, Oak Associates held 161 positions worth $1.49B, up 4.2% from $1.43B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Oak Associates's Q2 2018 filing shows 4 new, 69 increased, 20 reduced and 5 closed positions. Its largest new stake was Perspecta Inc. Common Stock: 28,830 shares worth $592K. The largest sale was CSRA Inc., an estimated $13.6M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 36% a quarter earlier, followed by Financials and Communication Services.

  • Oak Associates's largest Q2 2018 buy was Perspecta Inc. Common Stock: 28,830 shares worth $592K.
  • Oak Associates added most to Novartis in Q2 2018, an estimated $10.9M increase.
  • Oak Associates's biggest Q2 2018 reduction was JPMorgan Chase, cutting an estimated $9.98M.
  • Oak Associates fully exited CSRA Inc. in Q2 2018, selling an estimated $13.6M.
  • Oak Associates's ten largest holdings make up 38% of its $1.49B portfolio in Q2 2018.
  • Oak Associates opened 4 new positions and closed 5 in Q2 2018.
  • Oak Associates's portfolio value rose 4.2% quarter-over-quarter to $1.49B.

Based on Oak Associates's 13F filing for Q2 2018, filed 14 Aug 2018.